We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.50 | -0.09% | 1,639.00 | 1,638.50 | 1,639.50 | 1,647.00 | 1,634.00 | 1,638.50 | 848,448 | 14:22:56 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.66 | 67.33B |
From Apr 2019 to Apr 2024
TIDMGSK
RNS Number : 0510F
GlaxoSmithKline PLC
12 May 2017
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc ------------------------------------------------------------ -------------------------------------------------------- Name of scheme: GlaxoSmithKline Share Option Plan - Ordinary Shares ------------------------------------------------------------ -------------------------------------------------------- Period of return: From: 1 November 2016 To: 30 April 2017 ---------------------------------- ------------------------ ------------------------- ------ --------------------- Balance of unallotted securities under scheme(s) from previous return: 3,530,802 ------------------------------------------------------------ -------------------------------------------------------- Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 2,142,952(1) ------------------------------------------------------------ -------------------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 1,569,653 ------------------------------------------------------------ -------------------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 4,104,101 ------------------------------------------------------------ -------------------------------------------------------- (1) This figure includes an adjustment of +142,952 unallotted securities that were allotted under the GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan but originally debited from the balance for this Scheme. ---------------------------------------------------------------------------------------------------------------------- Name of contact: Victoria Whyte ------------------------------ --------------- Telephone number of contact: 020 8047 5000 ------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc ------------------------------------------------------------------------ -------------------------------------------- Name of scheme: GlaxoSmithKline Share Option Plan - ADS ------------------------------------------------------------------------ -------------------------------------------- Period of return: From: 1 November 2016 To: 30 April 2017 ---------------------------------------------- ------------------------ ------------------- ----- ---------------- Balance of unallotted securities under scheme(s) from previous return: 9,349,738 ------------------------------------------------------------------------ -------------------------------------------- Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 0 ------------------------------------------------------------------------ -------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 553,924 ------------------------------------------------------------------------ -------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 8,795,814 ------------------------------------------------------------------------ -------------------------------------------- Name of contact: Victoria Whyte ------------------------------ --------------- Telephone number of contact: 020 8047 5000 ------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc -------------------------------------------------------------------------- ------------------------------------------ Name of scheme: Glaxo Wellcome UK Share Option Scheme -------------------------------------------------------------------------- ------------------------------------------ Period of return: From: 1 November 2016 To: 30 April 2017 ------------------------------------------------ ------------------------ ------------------ ----- --------------- Balance of unallotted securities under scheme(s) from previous return: 5,119,750 -------------------------------------------------------------------------- ------------------------------------------ Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 0 -------------------------------------------------------------------------- ------------------------------------------ Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 0 -------------------------------------------------------------------------- ------------------------------------------ Equals: Balance under scheme(s) not yet issued/allotted at end of period: 5,119,750 -------------------------------------------------------------------------- ------------------------------------------ Name of contact: Victoria Whyte ------------------------------ --------------- Telephone number of contact: 020 8047 5000 ------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc --------------------------------------------------------------- ----------------------------------------------------- Name of scheme: Glaxo Wellcome International Share Option Scheme --------------------------------------------------------------- ----------------------------------------------------- Period of return: From: 1 November 2016 To: 30 April 2017 ------------------------------------- ------------------------ ------------------------ ----- -------------------- Balance of unallotted securities under scheme(s) from previous return: 13,267,156 --------------------------------------------------------------- ----------------------------------------------------- Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 0 --------------------------------------------------------------- ----------------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 0 --------------------------------------------------------------- ----------------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 13,267,156 --------------------------------------------------------------- ----------------------------------------------------- Name of contact: Victoria Whyte ------------------------------ --------------- Telephone number of contact: 020 8047 5000 ------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc -------------------------------------------------------------------------- ------------------------------------------ Name of scheme: Glaxo Wellcome 1999 Share Option Plan -------------------------------------------------------------------------- ------------------------------------------ Period of return: From: 1 November 2016 To: 30 April 2017 ------------------------------------------------ ------------------------ ------------------ ----- --------------- Balance of unallotted securities under scheme(s) from previous return: 1,040,000 -------------------------------------------------------------------------- ------------------------------------------ Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 0 -------------------------------------------------------------------------- ------------------------------------------ Less: Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G): 0 -------------------------------------------------------------------------- ------------------------------------------ Equals: Balance under scheme(s) not yet issued/allotted at end of period: 1,040,000 -------------------------------------------------------------------------- ------------------------------------------ Name of contact: Victoria Whyte ------------------------------ --------------- Telephone number of contact: 020 8047 5000 ------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
Hot Features
Premium
Name of applicant: GlaxoSmithKline plc
---------------------------------------------------- ----------------------------------------------------------------
Name of scheme: SmithKline Beecham 1989 Executive Share Option Plan - Approved
- Ordinary Shares
---------------------------------------------------- ----------------------------------------------------------------
Period of return: From: 1 November 2016 To: 30 April 2017
-------------------------- ------------------------ ------------------------- --------- --------------------------
Balance of unallotted securities under scheme(s)
from previous return: 163,606
---------------------------------------------------- ----------------------------------------------------------------
Plus: The amount by which the block scheme(s) has
been increased since the date of the last
return (if any increase has been applied for): 0
---------------------------------------------------- ----------------------------------------------------------------
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G): 0
---------------------------------------------------- ----------------------------------------------------------------
Equals: Balance under scheme(s) not yet
issued/allotted at end of period: 163,606
---------------------------------------------------- ----------------------------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc
---------------------------------------------------- ----------------------------------------------------------------
Name of scheme: SmithKline Beecham 1989 Executive Share Option Plan -
Unapproved - ADS
---------------------------------------------------- ----------------------------------------------------------------
Period of return: From: 1 November 2016 To: 30 April 2017
-------------------------- ------------------------ -------------------------- -------- --------------------------
Balance of unallotted securities under scheme(s)
from previous return: 275,420
---------------------------------------------------- ----------------------------------------------------------------
Plus: The amount by which the block scheme(s) has
been increased since the date of the last
return (if any increase has been applied for): 0
---------------------------------------------------- ----------------------------------------------------------------
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G): 0
---------------------------------------------------- ----------------------------------------------------------------
Equals: Balance under scheme(s) not yet
issued/allotted at end of period: 275,420
---------------------------------------------------- ----------------------------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc
---------------------------------------------------- ----------------------------------------------------------------
Name of scheme: SmithKline Beecham 1989 Executive Share Option Plan -
Unapproved - Ordinary
---------------------------------------------------- ----------------------------------------------------------------
Period of return: From: 1 November 2016 To: 30 April 2017
-------------------------- ------------------------ ------------------------- --------- --------------------------
Balance of unallotted securities under scheme(s)
from previous return: 100,000
---------------------------------------------------- ----------------------------------------------------------------
Plus: The amount by which the block scheme(s) has
been increased since the date of the last
return (if any increase has been applied for): 0
---------------------------------------------------- ----------------------------------------------------------------
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G): 0
---------------------------------------------------- ----------------------------------------------------------------
Equals: Balance under scheme(s) not yet
issued/allotted at end of period: 100,000
---------------------------------------------------- ----------------------------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc
--------------------------------------------------- -----------------------------------------------------------------
Name of scheme: GlaxoSmithKline Savings Related Share Option Scheme
--------------------------------------------------- -----------------------------------------------------------------
Period of return: From: 1 November 2016 To: 30 April 2017
------------------------- ------------------------ ------------------------- ----------- -------------------------
Balance of unallotted securities under scheme(s)
from previous return: 2,742,626
--------------------------------------------------- -----------------------------------------------------------------
Plus: The amount by which the block scheme(s) has
been increased since the date of the last
return (if any increase has been applied for): 0
--------------------------------------------------- -----------------------------------------------------------------
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G): 0
--------------------------------------------------- -----------------------------------------------------------------
Equals: Balance under scheme(s) not yet 2,742,626 (the GlaxoSmithKline Savings Related Share Option
issued/allotted at end of period: Scheme has now expired. The balance
of 2,742,626 un-allotted shares under this Scheme has therefore
lapsed)
--------------------------------------------------- -----------------------------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc ----------------------------------------------------------------------- --------------------------------------------- Name of scheme: GlaxoSmithKline plc Share Save Plan 2012 ----------------------------------------------------------------------- --------------------------------------------- Period of return: From: 1 November 2016 To: 30 April 2017 --------------------------------------------- ------------------------ -------------------- ----- ---------------- Balance of unallotted securities under scheme(s) from previous return: 239,107 ----------------------------------------------------------------------- --------------------------------------------- Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 2,000,000 ----------------------------------------------------------------------- --------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 603,782 ----------------------------------------------------------------------- --------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 1,635,325 ----------------------------------------------------------------------- --------------------------------------------- Name of contact: Victoria Whyte ------------------------------ --------------- Telephone number of contact: 020 8047 5000 ------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc ------------------------------------------------------------ -------------------------------------------------------- Name of scheme: GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan ------------------------------------------------------------ -------------------------------------------------------- Period of return: From: 1 November 2016 To: 30 April 2017 ---------------------------------- ------------------------ ------------------------- ------ --------------------- Balance of unallotted securities under scheme(s) from previous return: 0 ------------------------------------------------------------ -------------------------------------------------------- Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 600,000 ------------------------------------------------------------ -------------------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 399,929(1) ------------------------------------------------------------ -------------------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 200,071 ------------------------------------------------------------ -------------------------------------------------------- (1) This figure includes an adjustment of +142,952 allotted securities that were allotted under this Scheme but originally debited from the balance for the block listing under the GlaxoSmithKline Share Option Plan - Ordinary Shares. ---------------------------------------------------------------------------------------------------------------------- Name of contact: Victoria Whyte ------------------------------ --------------- Telephone number of contact: 020 8047 5000 ------------------------------ ---------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRZMGMKKZZGNZM
(END) Dow Jones Newswires
May 12, 2017 11:26 ET (15:26 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
